Suchergebnisse - "Fiala, Ondrej"

PubPharm (141)

1

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy : the ARON-2 study

enthalten in: Cancer immunology, immunotherapy : CII | 2024

von Massari, F. | Santoni, M. | Takeshita, H. | +94

2

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study

enthalten in: Cancer immunology immunotherapy | 2024

von Massari, F. | Santoni, M. | Takeshita, H. | +94

3

External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations

enthalten in: Clinical & experimental metastasis | 2024

von Maffezzoli, M. | Santoni, M. | Mazzaschi, G. | +24

4

Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma : Insights From the ARON-1 Study

enthalten in: Clinical genitourinary cancer | 2024

von Monteiro, F. | Fiala, O. | Massari, F. | +17

5

Papillary Renal Cell Carcinoma : Outcomes for Patients Receiving First-line Immune-based Combinations or Tyrosine Kinase Inhibitors from the ARON-1 Study

enthalten in: European urology oncology | 2024

von Massari, F. | Mollica, V. | Fiala, O. | +21

6

Alpha-methyl CoA racemase (AMACR) reactivity across the spectrum of clear cell renal cell neoplasms

enthalten in: Annals of diagnostic pathology | 2024

von Rotterova, P. | Alaghehbandan, R. | Skopal, J. | +14

7

External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations

enthalten in: Clinical & experimental metastasis | 2024

von Maffezzoli, M. | Santoni, M. | Mazzaschi, G. | +24

8

Pembrolizumab plus enfortumab vedotin in urothelial cancer

enthalten in: Nature reviews. Urology | 2024

von Santoni, M. | Takeshita, H. | Massari, F. | +7

9

Concomitant antihypertensive medication and outcome of patients with metastatic castration-resistant prostate cancer receiving enzalutamide or abiraterone acetate

enthalten in: Cancer medicine | 2024

von Fiala, O. | Hošek, P. | Korunková, H. | +9

10

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations : Differential Effectiveness by Risk Group?

enthalten in: European urology oncology | 2024

von Santoni, M. | Buti, S. | Myint, Z. | +63

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]